Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $2.60 billion. The enterprise value is $5.33 billion.
Important Dates
The next confirmed earnings date is Friday, November 8, 2024, before market open.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 309.54 million shares outstanding. The number of shares has increased by 66.75% in one year.
| Shares Outstanding | 309.54M |
| Shares Change (YoY) | +66.75% |
| Shares Change (QoQ) | +3.80% |
| Owned by Insiders (%) | 52.82% |
| Owned by Institutions (%) | 43.29% |
| Float | 141.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.17 |
| PS Ratio | 0.82 |
| Forward PS | 0.93 |
| PB Ratio | n/a |
| P/FCF Ratio | 12.55 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 25.72.
| EV / Earnings | n/a |
| EV / Sales | 2.05 |
| EV / EBITDA | 9.26 |
| EV / EBIT | 15.19 |
| EV / FCF | 25.72 |
Financial Position
The company has a current ratio of 1.33
| Current Ratio | 1.33 |
| Quick Ratio | 0.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.56 |
| Debt / FCF | 13.14 |
| Interest Coverage | 1.45 |
Financial Efficiency
Return on equity (ROE) is -148.99% and return on invested capital (ROIC) is 7.62%.
| Return on Equity (ROE) | -148.99% |
| Return on Assets (ROA) | 6.09% |
| Return on Capital (ROIC) | 7.62% |
| Revenue Per Employee | $330,954 |
| Profits Per Employee | -$22,244 |
| Employee Count | 7,850 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, AMRX has paid $17.58 million in taxes.
| Income Tax | 17.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.04% in the last 52 weeks. The beta is 1.17, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +96.04% |
| 50-Day Moving Average | 8.53 |
| 200-Day Moving Average | 6.93 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 757,276 |
Short Selling Information
The latest short interest is 4.18 million, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 4.18M |
| Short Previous Month | 4.64M |
| Short % of Shares Out | 1.35% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
In the last 12 months, AMRX had revenue of $2.60 billion and -$174.62 million in losses. Loss per share was -$0.69.
| Revenue | 2.60B |
| Gross Profit | 965.11M |
| Operating Income | 351.16M |
| Pretax Income | -157.04M |
| Net Income | -174.62M |
| EBITDA | 576.39M |
| EBIT | 351.16M |
| Loss Per Share | -$0.69 |
Full Income StatementBalance Sheet
The company has $47.22 million in cash and $2.73 billion in debt, giving a net cash position of -$2.68 billion or -$8.65 per share.
| Cash & Cash Equivalents | 47.22M |
| Total Debt | 2.73B |
| Net Cash | -2.68B |
| Net Cash Per Share | -$8.65 |
| Equity (Book Value) | -4.07M |
| Book Value Per Share | -0.19 |
| Working Capital | 371.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $252.46 million and capital expenditures -$45.03 million, giving a free cash flow of $207.43 million.
| Operating Cash Flow | 252.46M |
| Capital Expenditures | -45.03M |
| Free Cash Flow | 207.43M |
| FCF Per Share | $0.67 |
Full Cash Flow StatementMargins
Gross margin is 37.15%, with operating and profit margins of 13.52% and -6.72%.
| Gross Margin | 37.15% |
| Operating Margin | 13.52% |
| Pretax Margin | -4.45% |
| Profit Margin | -6.72% |
| EBITDA Margin | 22.19% |
| EBIT Margin | 13.52% |
| FCF Margin | 7.98% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -66.75% |
| Shareholder Yield | -66.75% |
| Earnings Yield | -6.71% |
| FCF Yield | 7.97% |
Dividend DetailsAnalyst Forecast
The average price target for AMRX is $9.00, which is 7.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 7.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMRX has an Altman Z-Score of 1.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 6 |